At CM4Cure, we’re revolutionizing medical devices by effectively combating infection and thrombosis. As a spin-off from the University of Liège in Sart-Tilman (Liège, Belgium), our team integrates decades of breakthrough research and technical expertise into a single goal: improving patient care and safety.
Our innovative nanoreservoir coating technology, combined with proprietary API formulations, addresses both blood clotting (thrombosis) and infection risk—two critical challenges that cost healthcare systems billions and pose life-threatening risks to patients worldwide. Our mission is simple: transform patient outcomes and reshape the industry of insertable and implantable medical devices, as well as topical antimicrobial care.
Whether you’re a manufacturer seeking advanced solutions or an investor looking to support groundbreaking healthcare innovations, join us on this exciting journey —and together, we’ll craft your next success story.
We continuously strive to advance product development and expand the applications of our coating technologies and proprietary API formulations to new medical devices and antimicrobial topical healthcare solutions. Our secured funding and strategic partnerships underpin our future advancements and sustainability.
Successfully secured over €6M through prestigious EU Horizon grants, support from the Walloon Region (Belgium), and strategic shareholder investments.
Planned through non-dilutive grants, strategic partnerships, and equity investment to fuel ongoing innovation and market expansion.
Partnering with leading medical device companies to co-develop, scale, and distribute CM4Cure’s advanced coatings tailored for specific applications.
A robust testing and development plan will pave the way toward regulatory approval, enabling broad market adoption.
CM4Cure pioneers healthcare innovation by expanding a transformative pipeline of cutting-edge solutions that redefine impact across established and emerging medical markets.
Our technology and product pipeline focus on high-impact medical devices, specifically targeting the critical risks of infection and thrombosis. Our initial application is in intravenous catheters, with plans for future expansion into other implantable devices and topical antimicrobial treatments.
Intellectual Property
Upgrade your manufacturing processes and product portfolio with CM4Cure’s cutting-edge solutions to simultaneously reduce infection and thrombosis. Our unique API formulations and our technology to apply coatings both inside and outside medical devices sets us apart in the industry.
By partnering with CM4Cure, you will gain:
“The future of safer, more effective medical devices is here. Let’s revolutionize patient care and drive lasting impact in healthcare together.
Invest in the future. Invest in health. Invest in safety.!
